Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Lundqvist

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Arzneimittel-Forschung|August 19, 2007
Food interaction of oral uptake of iron / a clinical trial using 59FeHans Lundqvist, Folke Sjöberg
Biopolymers|March 27, 2003
Targeting peptides and positron emission tomographyHans Lundqvist, Vladimir Tolmachev
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclidesVladimir Tolmachev, Jörgen Carlsson, Hans Lundqvist
Physics in Medicine and Biology|March 20, 2002
Production, PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapyMark Lubberink, Hans Lundqvist, Vladimir Tolmachev
Journal of Molecular Recognition : JMR|April 29, 2008
Characterization of 111In and 177Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassayMarika Nestor, Karl Andersson, Hans Lundqvist
European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2006
Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapyJörgen Carlsson, Veronika Eriksson, Bo Stenerlöw, et al.
Physics in Medicine and Biology|November 1, 2002
Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PETMark Lubberink, Harald Schneider, Mats Bergström, et al.
Medical Physics|May 8, 2012
Exploring (57)Co as a new isotope for brachytherapy applicationsShirin A Enger, Hans Lundqvist, Michel D'Amours, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2009
Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotateMattias Sandström, Ulrike Garske, Dan Granberg, et al.
Biotechniques|March 12, 2008
Real-time viability assay based on 51Cr retention in adherent cellsLina Vennström, Camilla Bysell, Hanna Björkelund, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Arzneimittel-Forschung|August 19, 2007
Food interaction of oral uptake of iron / a clinical trial using 59FeHans Lundqvist, Folke Sjöberg
Biopolymers|March 27, 2003
Targeting peptides and positron emission tomographyHans Lundqvist, Vladimir Tolmachev
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclidesVladimir Tolmachev, Jörgen Carlsson, Hans Lundqvist
Physics in Medicine and Biology|March 20, 2002
Production, PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapyMark Lubberink, Hans Lundqvist, Vladimir Tolmachev
Journal of Molecular Recognition : JMR|April 29, 2008
Characterization of 111In and 177Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassayMarika Nestor, Karl Andersson, Hans Lundqvist
European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2006
Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapyJörgen Carlsson, Veronika Eriksson, Bo Stenerlöw, et al.
Physics in Medicine and Biology|November 1, 2002
Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PETMark Lubberink, Harald Schneider, Mats Bergström, et al.
Medical Physics|May 8, 2012
Exploring (57)Co as a new isotope for brachytherapy applicationsShirin A Enger, Hans Lundqvist, Michel D'Amours, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2009
Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotateMattias Sandström, Ulrike Garske, Dan Granberg, et al.
Biotechniques|March 12, 2008
Real-time viability assay based on 51Cr retention in adherent cellsLina Vennström, Camilla Bysell, Hanna Björkelund, et al.
Pageof 5